FDA clears its first blood test for diagnosing Alzheimer's disease, with Fujirebio's Lumipulse
The FDA said the blood test can help reduce the need for taking invasive CSF samples or scheduling expensive PET brain scans.
The FDA said the blood test can help reduce the need for taking invasive CSF samples or scheduling expensive PET brain scans.
